StemCutis has an exclusive, worldwide Stemedica license for indications in the skin care and dermatology fields. As part of the license, StemCutis also has full rights to any Stemedica clinical and pre-clinical protocols and results of any pre-clinical and clinical trials associated with skin care and dermatology conditions.
The StemCutis executive team has extensive expertise in medical research and launching successful biotech companies, especially in the fields of stem cells and laser technologies. The laser technology developed and commercialized by StemCutis’ co-founders has been used extensively worldwide by dermatologists and cosmetic surgeons.
StemCutis uses parent company Stemedica’s itMSC stem cells and stem cell factors, which are manufactured in a cGMP-compliant facility licensed by the State of California Department of Public Health Food and Drug Branch (FDB). StemCutis retains exclusive access to the itMSCs and any future modifications for indications in the skin care and dermatology fields.